MRD in AML

[SY7-4] Monitoring MRD targeting genetic alterations and aberrant immunophenotypes in pediatric AML

Takashi Taga (Pediatr., Shiga Med. Univ., Otsu, Japan)

Professional Experience and Education
1986-1988 Resident, Department of Pediatrics, Shiga University of Medical Science
1988-1993 Postdoctoral course, Shiga University of Medical Science
1993-1995 Department of Pediatrics, Nagahama Red Cross Hospital
1995-2009 Assistant Professor, Department of Pediatrics, Shiga University of Medical Science
1998-2000 Postdoctoral fellow, Department Hematology andOncology, Childrens Hospital of Los Angeles
2009-2017 Lecturer, Department of Pediatrics, Shiga University of Medical Science
2018- Associate Professor, Department of Pediatrics, Shiga University of Medical Science
2019- Clinical professor, Shiga University Hospital
Other activities and Honors
2009 Otani Award of Japanese Society of Pediatric Hematology
2013 Excellent Researcher Award of Shiga University of Medical Science
2013 Academic Prize of Japanese Society of Pediatric Hematology and Oncology
2014-2019 Chairman of Japanese Childrens Oncology Group (JCCG) AML committee
2017-2019 Chairman of JCCG protocol review committee
2017- Executive board member of JCCG